Directory section navigation

Profile

Jennifer Spangle

  • Department of Radiation Oncology
    Assistant Professor
Head shot of Jennifer Spangle

Overview

Jennifer M. Spangle, PhD, joined the Department of Radiation Oncology at Emory University School of Medicine in August 2019 as Assistant Professor. Prior to joining Emory, Dr. Spangle was Instructor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School.

Dr. Spangle graduated with honors from the University of Arizona with a BS in Molecular and Cellular Biology. She earned her PhD in Virology from Harvard Medical School in Boston, Massachusetts. She completed her postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts, where she was the American Cancer Society Lee Denim Postdoctoral Fellow.

Academic Appointment

  • Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

  • PhD from Harvard University

Research

Focus

  • Unlocking novel therapies through the PI3K pathway

    The Spangle laboratory is committed to understanding how PI3K-mediated regulation of the epigenome contributes to cancer development and modulates treatment response. The PI3K signaling pathways is aberrantly activated in more than 40% of breast and other cancers, and yet mono- and combination therapies resulting in durable PI3K inhibition are still in development. Her research program hopes to utilize PI3K-mediated epigenetic rewiring to identify actionable targets and durable and efficacious combination therapies for the treatment of PI3K-activated cancers. The Spangle lab is specifically focusing on the mechanisms by which H3K4-directed demethylases and methyltransferases mediate resistance to PI3K inhibitors in cancer and how AKT regulates histone phosphorylation and transcriptional competence in normal tissue and how this process is deregulated in cancer.

Publications

Read more publications